Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kadri Altundag

Showing results (131-140 of 151) with videos related to

Pageof 16
Sort By:
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|May 27, 2015
Chemotherapy might not be beneficial in lymph node- negative, hormone-positive, and HER2-negative breast cancer patients: a long-term retrospective analysisTaner Babacan, Hakan Buyukhatipoglu, Ozan Balakan, et al.
Japanese Journal of Clinical Oncology|January 9, 2004
Biweekly irinotecan plus bolus 5-fluorouracil and folinic acid in patients with advanced stage colorectal cancerSuayib Yalcin, Berna Oksuzoglu, Gülten Tekuzman, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 18, 2015
A retrospective analysis of adjuvant CAF, AC-T and TAC regimens in triple negative early stage breast cancerHakan Buyukhatipoglu, Taner Babacan, Neyran Kertmen, et al.
Cancer Investigation|June 11, 2005
A phase II study on the safety and efficacy of 5-fluorouracil, epirubicin, cyclophosphamide (FEC) followed by paclitaxel in the adjuvant treatment of breast cancerMustafa Erman, Esmen Baltali, Aziz Karaoglu, et al.
Journal of Neuro-Oncology|September 1, 2005
Brain metastasis of cardiac myxoma: case report and review of the literatureMuzaffer B Altundag, Gulcin Ertas, Ali R Ucer, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 9, 2016
Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancerOzturk Ates, Taner Babacan, Neyran Kertmen, et al.
Medical Oncology (Northwood, London, England)|May 18, 2010
Optimal timing of adjuvant treatment in patients with early breast cancerNecati Alkis, Ayse G Durnali, Ulku Y Arslan, et al.
Clinical Breast Cancer|October 21, 2016
Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast CancerSaverio Cinieri, Arlene Chan, Kadri Altundag, et al.
Anticancer Research|February 11, 2015
Which sequence best protects the heart against trastuzumab and anthracycline toxicity? An electron microscopy study in ratsNeyran Kertmen, Sercan Aksoy, Aysegul Uner, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|February 17, 2015
Associations among physical activity, comorbidity, functional capacity, peripheral muscle strength and depression in breast cancer survivorsNaciye Vardar-Yagli, Gul Sener, Melda Saglam, et al.
Pageof 16

Showing results (131-140 of 151) with videos related to

Sort By:
Pageof 16
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|May 27, 2015
Chemotherapy might not be beneficial in lymph node- negative, hormone-positive, and HER2-negative breast cancer patients: a long-term retrospective analysisTaner Babacan, Hakan Buyukhatipoglu, Ozan Balakan, et al.
Japanese Journal of Clinical Oncology|January 9, 2004
Biweekly irinotecan plus bolus 5-fluorouracil and folinic acid in patients with advanced stage colorectal cancerSuayib Yalcin, Berna Oksuzoglu, Gülten Tekuzman, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 18, 2015
A retrospective analysis of adjuvant CAF, AC-T and TAC regimens in triple negative early stage breast cancerHakan Buyukhatipoglu, Taner Babacan, Neyran Kertmen, et al.
Cancer Investigation|June 11, 2005
A phase II study on the safety and efficacy of 5-fluorouracil, epirubicin, cyclophosphamide (FEC) followed by paclitaxel in the adjuvant treatment of breast cancerMustafa Erman, Esmen Baltali, Aziz Karaoglu, et al.
Journal of Neuro-Oncology|September 1, 2005
Brain metastasis of cardiac myxoma: case report and review of the literatureMuzaffer B Altundag, Gulcin Ertas, Ali R Ucer, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 9, 2016
Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancerOzturk Ates, Taner Babacan, Neyran Kertmen, et al.
Medical Oncology (Northwood, London, England)|May 18, 2010
Optimal timing of adjuvant treatment in patients with early breast cancerNecati Alkis, Ayse G Durnali, Ulku Y Arslan, et al.
Clinical Breast Cancer|October 21, 2016
Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast CancerSaverio Cinieri, Arlene Chan, Kadri Altundag, et al.
Anticancer Research|February 11, 2015
Which sequence best protects the heart against trastuzumab and anthracycline toxicity? An electron microscopy study in ratsNeyran Kertmen, Sercan Aksoy, Aysegul Uner, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|February 17, 2015
Associations among physical activity, comorbidity, functional capacity, peripheral muscle strength and depression in breast cancer survivorsNaciye Vardar-Yagli, Gul Sener, Melda Saglam, et al.
Pageof 16